Natural Product: NPC35390

Natural Product IDNPC35390
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Methyllycaconitine
IUPAC Name n.a.
Synonyms Methyllycaconitine; Methyllycanonitine
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL510275
PubChem CID 44575473
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids
          • [CHEMONTID:0003788] Aconitane-type diterpenoid alkaloids

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey XLTANAWLDBYGFU-BVFBBISOSA-N
Standard InCHI InChI=1S/C37H50N2O10/c1-7-38-17-34(18-49-32(42)20-10-8-9-11-23(20)39-26(40)14-19(2)31(39)41)13-12-25(46-4)36-22-15-21-24(45-3)16-35(43,27(22)28(21)47-5)37(44,33(36)38)30(48-6)29(34)36/h8-11,19,21-22,24-25,27-30,33,43-44H,7,12-18H2,1-6H3/t19-,21+,22+,24-,25-,27+,28-,29+,30-,33-,34-,35+,36-,37-/m0/s1
SMILES CCN1C[C@@]2(CC[C@@H]([C@]34[C@H]1[C@@](O)([C@H]([C@H]23)OC)[C@@]1([C@@H]2[C@H]4C[C@@H]([C@@H]2OC)[C@H](C1)OC)O)OC)COC(=O)c1ccccc1N1C(=O)C[C@@H](C1=O)C

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   682.35 Volume:   674.133
?
Van der Waals volume.
Dense:   1.012 LogP:   1.846
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   2.16
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -3.324
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   10.0 Rigid Bonds:   38.0
TPSA:   144.3
?
Topological Polar Surface Area.
H-Bond Acceptor:   12.0
H-Bond Donor:   2.0 Rings:   8.0
Heavy Atoms:   12.0

MedChem Properties

QED Drug-Likeness Score:   0.292 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   7.255 Fsp3:   0.757
MCE-18:   244.615
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.478 Fluc inhibitor:   0.001
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.01
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.006
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.002 Promiscuous compounds:   0.649

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.374 MDCK Permeability:   -5.146
Pgp-inhibitor:   0.0 Pgp-substrate:   0.26
PAMPA:   0.977
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.0
20% Bioavailability (F20%):   0.014 30% Bioavailability (F30%):   0.001
50% Bioavailability (F50%):   0.058

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.035 MRP1:   0.996
Plasma Protein Binding (PPB):   81.91% Volume Distribution (VD):   0.166
Fu: 21.048%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.607
OATP1B3 inhibitor:   0.416 BCRP inhibitor:   0.0
BSEP inhibitor:   0.661

ADMET: Metabolism

CYP1A2-inhibitor:   0.925 CYP1A2-substrate:   0.352
CYP2C19-inhibitor:   0.967 CYP2C19-substrate:   0.535
CYP2C9-inhibitor:   0.05 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.642
CYP3A4-inhibitor:   0.407 CYP3A4-substrate:   0.026
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.294
HLM stability:   0.989
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  3.69 Half-life (T1/2):  2.017

ADMET: Toxicity

hERG Blockers:  0.062 hERG Blockers (10um):  0.299
Human Hepatotoxicity (H-HT):  0.259 Drug-induced Liver Injury (DILI):  0.899
AMES Toxicity:  0.664 Rat Oral Acute Toxicity:  0.262
Maximum Recommended Daily Dose:  0.245 Skin Sensitization:  0.998
Carcinogencity:  0.721 Eye Corrosion:  0.0
Eye Irritation:  0.053 Respiratory Toxicity:  0.771
Drug-induced Neurotoxicity:  0.895 Ototoxicity:  0.733
Hematotoxicity:  0.838 Drug-induced Nephrotoxicity:  0.927
Genotoxicity:  1.0 RPMI-8226 Immunitoxicity:  0.07
A549 Cytotoxicity:  0.192 Hek293 Cytotoxicity:  0.769
BCF:   0.76
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.885
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.051
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.782
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32441 delphinium sp. Species Ranunculaceae Eukaryota n.a. n.a. n.a. PMID[9748371]
NPO32441 delphinium sp. Species Ranunculaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT416 Protein complex Neuronal acetylcholine receptor; alpha3/beta2 Rattus norvegicus Ki = 2.3 nM PMID[19743809]
NPT1783 Protein complex Serotonin 3 (5-HT3) receptor Homo sapiens Ki = 16.5 % PubChem BioAssay data set
NPT412 Protein complex Neuronal acetylcholine receptor; alpha4/beta2 Rattus norvegicus Ki = 1560.0 nM PMID[14640526]
NPT412 Protein complex Neuronal acetylcholine receptor; alpha4/beta2 Rattus norvegicus Ki = 1460.0 nM PMID[21440449]
NPT6604 Individual protein Neuronal acetylcholine receptor protein alpha-10 subunit Rattus norvegicus Ki = 1300.0 nM PMID[20158243]
NPT409 Protein complex Neuronal acetylcholine receptor; alpha4/beta2 Homo sapiens Concentration > 1.0 % PMID[16033252]
NPT3921 Protein complex Neuronal acetylcholine receptor; alpha2/beta4 Homo sapiens IC50 > 1000.0 nM DOI[10.6019/CHEMBL1201861]
NPT3920 Protein complex Neuronal acetylcholine receptor; alpha4/beta4 Homo sapiens Concentration > 1.0 uM PMID[16033252]
NPT409 Protein complex Neuronal acetylcholine receptor; alpha4/beta2 Homo sapiens Ki > 10000.0 nM PMID[16643041]
NPT412 Protein complex Neuronal acetylcholine receptor; alpha4/beta2 Rattus norvegicus Ki = 400.0 nM PMID[8759171]
NPT410 Individual protein Neuronal acetylcholine receptor protein alpha-7 subunit Homo sapiens Blockage = 100.0 % PMID[15050620]
NPT6298 Protein complex Chromaffin cell neuronal nicotinic acetylcholine receptor Bos taurus Inhibition = 95.2 % PMID[22801644]
NPT410 Individual protein Neuronal acetylcholine receptor protein alpha-7 subunit Homo sapiens IC50 > 1000.0 nM DOI[10.6019/CHEMBL1201861]
NPT410 Individual protein Neuronal acetylcholine receptor protein alpha-7 subunit Homo sapiens Ki = 7.3 nM PubChem BioAssay data set
NPT410 Individual protein Neuronal acetylcholine receptor protein alpha-7 subunit Homo sapiens Ki = 1.1 nM DrugMatrix in vivo data: Pathology
NPT410 Individual protein Neuronal acetylcholine receptor protein alpha-7 subunit Homo sapiens Ki = 1.0 nM DrugMatrix in vivo data: Pathology
NPT410 Individual protein Neuronal acetylcholine receptor protein alpha-7 subunit Homo sapiens Ki = 6.1 nM PMID[11575949]
NPT410 Individual protein Neuronal acetylcholine receptor protein alpha-7 subunit Homo sapiens Ki = 6.31 nM PMID[19344127]
NPT410 Individual protein Neuronal acetylcholine receptor protein alpha-7 subunit Homo sapiens Ki = 1.6 nM PMID[17722904]
NPT410 Individual protein Neuronal acetylcholine receptor protein alpha-7 subunit Homo sapiens Ki = 1.622 nM PMID[17722904]
NPT410 Individual protein Neuronal acetylcholine receptor protein alpha-7 subunit Homo sapiens IC50 = 8.3 nM PMID[8176404]
NPT410 Individual protein Neuronal acetylcholine receptor protein alpha-7 subunit Homo sapiens IC50 = 8.318 nM PubChem BioAssay data set
NPT6362 Individual protein Neuronal acetylcholine receptor subunit alpha-3 Bos taurus Activity = 50.1 % PMID[19738026]
NPT414 Individual protein Neuronal acetylcholine receptor protein alpha-7 subunit Rattus norvegicus Ki = 1560.0 nM PMID[22925447]
NPT414 Individual protein Neuronal acetylcholine receptor protein alpha-7 subunit Rattus norvegicus Ki = 0.8 nM PMID[20045651]
NPT414 Individual protein Neuronal acetylcholine receptor protein alpha-7 subunit Rattus norvegicus Ki = 0.6 nM PMID[20045651]
NPT414 Individual protein Neuronal acetylcholine receptor protein alpha-7 subunit Rattus norvegicus Ki > 1000.0 nM PMID[20045651]
NPT414 Individual protein Neuronal acetylcholine receptor protein alpha-7 subunit Rattus norvegicus Ki = 2.3 nM PMID[16643041]
NPT414 Individual protein Neuronal acetylcholine receptor protein alpha-7 subunit Rattus norvegicus Ki = 4.8 nM PMID[17896816]
NPT414 Individual protein Neuronal acetylcholine receptor protein alpha-7 subunit Rattus norvegicus IC50 = 7.6 nM PMID[19128055]
NPT411 Protein complex Neuronal acetylcholine receptor; alpha3/beta4 Homo sapiens IC50 = 2600.0 nM PMID[18052325]
NPT423 Protein complex Neuronal acetylcholine receptor; alpha3/beta2 Homo sapiens IC50 > 1000.0 nM PMID[21856049]
NPT411 Protein complex Neuronal acetylcholine receptor; alpha3/beta4 Homo sapiens IC50 > 1000.0 nM DOI[10.6019/CHEMBL1201861]
NPT414 Individual protein Neuronal acetylcholine receptor protein alpha-7 subunit Rattus norvegicus Ki = 0.87 nM PMID[12713403]
NPT6221 Individual protein Neuronal acetylcholine receptor subunit alpha-7 Bos taurus Activity = 7.5 % PMID[11087617]
NPT414 Individual protein Neuronal acetylcholine receptor protein alpha-7 subunit Rattus norvegicus Ki = 4.0 nM PMID[17336534]
NPT414 Individual protein Neuronal acetylcholine receptor protein alpha-7 subunit Rattus norvegicus Ki = 2.91 nM PMID[17279798]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2 Others Unspecified n.a. Ki = 739.0 nM PMID[25679337]
NPT2 Others Unspecified n.a. Ki = 24.0 nM DrugMatrix in vitro pharmacology data
NPT2 Others Unspecified n.a. Ki = 23.99 nM DrugMatrix in vitro pharmacology data
NPT2 Others Unspecified n.a. Ki = 4.5 nM PMID[15771411]
NPT2 Others Unspecified n.a. Ki = 4.467 nM PMID[20060625]
NPT2 Others Unspecified n.a. Ki = 3.5 nM PMID[16792420]
NPT2 Others Unspecified n.a. Ki = 3.548 nM PMID[16792420]
NPT2 Others Unspecified n.a. Ki = 3.2 nM PMID[11063609]
NPT2 Others Unspecified n.a. Ki = 3.802 nM PMID[21377877]
NPT2 Others Unspecified n.a. Ki = 3.9 nM Open TG-GATES in vivo data: Hematology
NPT2 Others Unspecified n.a. Ki = 3.89 nM Open TG-GATES in vivo data: Hematology
NPT2 Others Unspecified n.a. Ki = 4.3 nM PMID[16506833]
NPT2 Others Unspecified n.a. Ki = 4.266 nM PMID[16506833]
NPT2 Others Unspecified n.a. Ki = 2.5 nM PMID[21612217]
NPT2 Others Unspecified n.a. Ki = 2.512 nM PMID[21612217]
NPT2 Others Unspecified n.a. Ki = 1.9 nM PMID[20478710]
NPT2 Others Unspecified n.a. Ki = 1.95 nM PMID[20478710]
NPT2 Others Unspecified n.a. Ki = 13.0 nM PMID[11374943]
NPT2 Others Unspecified n.a. Ki = 12.88 nM PMID[11374943]
NPT2 Others Unspecified n.a. Ki = 1.7 nM DOI[10.6019/CHEMBL1201861]
NPT2 Others Unspecified n.a. Ki = 1.66 nM PMID[16499324]
NPT2 Others Unspecified n.a. Ki = 5.5 nM PMID[23734721]
NPT2 Others Unspecified n.a. Ki = 5.495 nM PubChem BioAssay data set
NPT2 Others Unspecified n.a. IC50 = 10000.0 nM PMID[8864236]
NPT2 Others Unspecified n.a. IC50 = 31622.78 nM PMID[25066952]
NPT2 Others Unspecified n.a. IC50 = 89.0 nM PMID[23046382]
NPT2 Others Unspecified n.a. IC50 = 1800.0 nM Open TG-GATES in vivo data: Biochemistry
NPT2 Others Unspecified n.a. IC50 = 1819.7 nM PMID[22295903]
NPT2 Others Unspecified n.a. IC50 = 320.0 nM PubChem BioAssay data set
NPT2 Others Unspecified n.a. IC50 = 323.59 nM PubChem BioAssay data set
NPT2 Others Unspecified n.a. EC50 = 29512.09 nM PMID[15646539]
NPT2 Others Unspecified n.a. Ratio = 100.0 n.a. PMID[11374943]
NPT2 Others Unspecified n.a. Ratio = 1000.0 n.a. PMID[11374943]
NPT2 Others Unspecified n.a. Ratio = 10000.0 n.a. PMID[11374943]
NPT2 Others Unspecified n.a. Ki = 0.37 nM PMID[18183025]
NPT2 Others Unspecified n.a. Ki = 0.15 nM DOI[10.1016/S0960-894X(97)10055-5]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT32 Organism Mus musculus Mus musculus AD50 = 2.0 mg kg-1 PMID[18355033]
NPT32 Organism Mus musculus Mus musculus AD50 = 12.0 mg kg-1 PMID[18355033]
NPT32 Organism Mus musculus Mus musculus Activity = 15.0 % PMID[24766560]





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference
- Mus musculus LD50 = 7.5 mg.kg-1 PMID[24175613]
- Mus musculus LD50 = 3.0 mg.kg-1 PMID[17336534]

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC35390 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC611189
0.9333 High Similarity NPC470631
0.9333 High Similarity NPC481816
0.9022 High Similarity NPC481815
0.8876 High Similarity NPC473781
0.8021 Intermediate Similarity NPC475316
0.7812 Intermediate Similarity NPC473486
0.75 Intermediate Similarity NPC481814
0.7158 Intermediate Similarity NPC223590
0.6415 Remote Similarity NPC473667
0.6239 Remote Similarity NPC106593
0.6087 Remote Similarity NPC476501
0.5543 Remote Similarity NPC474210
0.5435 Remote Similarity NPC96080
0.5435 Remote Similarity NPC99905
0.5435 Remote Similarity NPC208118

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC35390 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data